Vascular markers linked to cognitive decline in diabetes

Vascular markers linked to cognitive decline in diabetes
Stroke and subclinical markers of macrovascular disease are associated with cognitive decline in older adults with type 2 diabetes, according to a study published online April 11 in Diabetes Care.

(HealthDay)—Stroke and subclinical markers of macrovascular disease are associated with cognitive decline in older adults with type 2 diabetes, according to a study published online April 11 in Diabetes Care.

Insa Feinkohl, from the University of Edinburgh in the United Kingdom, and colleagues measured signs of macrovascular disease in 831 cognitively healthy older adults with type 2 diabetes. Subjects underwent seven at baseline and after four years. Lifetime cognitive change was estimated by adjustment for vocabulary.

The researchers found a significant association between measures of cognitive decline and stroke, N-terminal probrain natriuretic peptide, ankle brachial index, and carotid intima-media thickness. There was a significant association between stroke and increased estimated lifetime cognitive decline, as well as between subclinical markers and actual four-year decline. Adjusting for had little effect. There was no association found between measures of cognitive decline and non-stroke vascular events.

"Stroke and subclinical markers of and generalized atherosclerosis are associated with in older patients with type 2 diabetes," Feinkohl and colleagues conclude.

The study was funded in part by Pfizer.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Vascular changes linked to dementia

Jul 21, 2011

The same artery-clogging process (atherosclerosis) that causes heart disease can also result in age-related vascular cognitive impairments (VCI), according to a new American Heart Association/American Stroke Association scientific ...

Recommended for you

Personalised treatment for stress-related diabetes

Oct 14, 2014

Researchers at Lund University in Sweden are testing a treatment for type 2 diabetes which targets the disease mechanism itself - and not just the symptoms. For the first time, knowledge about the individual patient's genetic ...

Sensors to simplify diabetes management

Oct 13, 2014

For many patients diagnosed with diabetes, treating the disease can mean a burdensome and uncomfortable lifelong routine of monitoring blood sugar levels and injecting the insulin that their bodies don't ...

Androgen receptor signaling tied to insulin resistance

Oct 09, 2014

(HealthDay)—Mouse models show tissue-specific androgen receptor (AR) signaling is involved in regulation of metabolism, which may explain the link between androgen deprivation therapy (ADT) and the development ...

User comments